HeartRhythm

SEPTEMBER 16, 2024

Implantable cardioverter-defibrillators (ICDs) are established as the standard of care for patients who are deemed at increased risk of life-threatening ventricular arrhythmias. Device-specific fears and symptoms of anxiety are the most common psychological sequelae experienced by ICD patients.1

Defibrillator 40

Defibrillator Quality of Life Arrhythmia 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

However, ventricular arrhythmias (VA) are common, are mostly secondary to underlying myocardial scar, and have a higher incidence in patients with pre-LVAD VA.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

DAIC

SEPTEMBER 5, 2024

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. tim.hodson Thu, 09/05/2024 - 16:02 Sept.

Defibrillator 52

Defibrillator Sudden Cardiac Death Quality of Life Tachycardia 52

HeartRhythm

AUGUST 31, 2024

Implantable cardioverter defibrillators (ICD) are effective at terminating ventricular arrhythmias (VA), though have significant drawbacks. The opportunity to predict the onset of arrhythmia holds promise for insight into VA initiation and the opportunity to deliver therapy prior to an event.

Arrhythmia 40

Arrhythmia Defibrillator 40

Circulation

NOVEMBER 11, 2024

The targeted Automated External Defibrillator (AED) program in the Sao Paulo Metro has yielded promising results in improving survival rates for individuals experiencing out-of-hospital cardiac arrest (OHCA) due to ventricular arrhythmias. Circulation, Volume 150, Issue Suppl_1 , Page ASu505-ASu505, November 12, 2024.

Cardiac Arrest 40

Cardiac Arrest Defibrillator Public Health Arrhythmia 40

HeartRhythm

APRIL 30, 2024

The Extravascular Implantable Cardioverter Defibrillator (EV ICD) has demonstrated to be efficacious in the treatment of ventricular arrhythmias. Predicators of lead rotation have yet to be elucidated. The management of patients affected by lead rotation is of clinical significance and not yet described.

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

MAY 23, 2024

Despite the implantable cardioverter defibrillator’s (ICD) effectiveness in saving patients with life-threatening ventricular arrhythmias (VAs), the temporal occurrence of VA following ICD implantation is unpredictable.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

JULY 14, 2024

The feasibility and safety of utilizing LBBAP lead to provide sensing of ventricular arrhythmia in patients receiving implantable cardioverter defibrillator(ICD) with CRT has been demonstrated recently

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.

Defibrillator 40

Defibrillator Sudden Cardiac Death Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

Open Heart

JULY 5, 2022

Automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs) are used to treat life-threatening arrhythmias. AEDs and ICDs use shock advice algorithms to classify ECG tracings as shockable or non-shockable rhythms in clinical practice.

Defibrillator 52

Defibrillator Cardiac Arrest Technology Arrhythmia 52

Open Heart

MARCH 8, 2024

The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death.

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Atrial Fibrillation Arrhythmia 52

HeartRhythm

DECEMBER 31, 2023

This 1997 figure is the first conclusive evidence that the implantable cardioverter-defibrillator (ICD) reduces overall mortality compared with drugs in patients with life-threatening ventricular arrhythmias (from The New England Journal of Medicine, reprinted with permission from Massachusetts Medical Society).1

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

APRIL 30, 2024

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.

Atrial Fibrillation 40

Atrial Fibrillation Defibrillator Sudden Cardiac Death Tachycardia 40

HeartRhythm

FEBRUARY 22, 2024

Arg14del) variant carriers are at risk of developing malignant ventricular arrhythmias (MVA). Accurate risk stratification allows for timely implantation of intracardiac defibrillators (ICD) and is currently performed using a multimodality prediction model. Phospholamban (PLN) p.(Arg14del)

Arrhythmia 40

Arrhythmia Defibrillator Cardiomyopathy 40

Heart BMJ

JANUARY 10, 2024

Automated external defibrillators (AEDs) have evolved as ‘game changers’ in the treatment of haemodynamically unstable ventricular arrhythmias as they can be used by virtually untrained members of the public. The usage of AEDs, however, can be improved as they are only employed in <20% of resuscitations.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiac Arrest Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 29, 2024

Abstract The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the traditional transvenous implantable cardioverter defibrillator (TV-ICD), aiming to provide easier implantation, simplified detection algorithm of malignant ventricular arrhythmias and prevention from placing components in the cardiovascular (..)

Defibrillator 40

Defibrillator Electrocardiogram Technology Arrhythmia 40

HeartRhythm

APRIL 30, 2024

However, we do not have data on P0PV1 and its association with ventricular arrhythmias.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

APRIL 30, 2024

Consequent implantable cardioverter-defibrillator (ICD) shocks can tremendously affect quality of life. Stereotactic arrhythmia radioablation (STAR) seems to reduce the number of ICD/external shocks, although most studies on STAR published to date only report results up to 12 months.

Arrhythmia 40

Arrhythmia Quality of Life Defibrillator Tachycardia 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 7, 2024

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.

Defibrillator 40

Defibrillator Sudden Cardiac Death Tachycardia Public Health 40

Open Heart

SEPTEMBER 1, 2022

Identifying patients with high-risk heart failure (HF) who would benefit from an implantable cardioverter-defibrillator (ICD) remains controversial. The molecular basis of the fQRS-arrhythmia-fibrosis connection in HF also needs to be explored. A potential marker for arrhythmic sudden death is fragmented QRS (fQRS).

Heart Failure 52

Heart Failure Arrhythmia Defibrillator 52

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundScreening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. We furthermore report treatment decisions because of incidental arrhythmias. We found incidental arrhythmias in 94 patients (11.8%). Journal of the American Heart Association, Ahead of Print. of our cohort patients.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Hospital Tachycardia 40

HeartRhythm

APRIL 30, 2024

We conducted this systematic review and meta-analysis to evaluate safety outcomes including risk of ventricular arrhythmias, new onset atrial fibrillation, Implantable Cardiac defibrillators (ICD) shocks, QRS duration reduction, heart failure hospitalizations and mortality.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

HeartRhythm

APRIL 30, 2024

The efficacy of implantable cardioverter-defibrillators (ICD) in patients with a non-ischaemic cardiomyopathy (NICM) is being debated. Deep Learning models enable feature extraction from high-dimensional data, such as cardiac MRI (CMR) and ECG.

Cardiomyopathy 40

Cardiomyopathy Defibrillator Arrhythmia 40

All About Cardiovascular System and Disorders

MARCH 28, 2024

An interesting fact is that many of the persons experience arrhythmias in Brugada syndrome with fever. So there is some relation between fever and precipitation of arrhythmias in Brugada syndrome. Of course, the commonest sustained arrhythmia in general population is atrial fibrillation.

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Arrhythmia Atrial Fibrillation 52

HeartRhythm

MARCH 12, 2024

Many patients with mild to moderately reduced left ventricular ejection fraction (LVEF) that require permanent pacemaker (PPM) implantation do not have a concurrent indication for implantable cardioverter-defibrillator (ICD) therapy. However, the risk of ventricular tachycardia/fibrillation (VT/VF) in this population is unknown.

Pacemaker 40

Pacemaker Defibrillator Arrhythmia Tachycardia 40

HeartRhythm

APRIL 30, 2024

In the PARTITA trial antitachycardia pacing (ATP) predicted the occurrence of implantable cardioverter-defibrillator (ICD) shocks. Catheter ablation of ventricular tachycardia after the first shock reduced the risk of death or worsening heart failure (wHF).

Defibrillator 40

Defibrillator Ablation Heart Failure Arrhythmia 40

Medical Xpress - Cardiology

APRIL 10, 2024

The late-breaking science was presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

Ablation 59

Ablation Hospital Tachycardia Defibrillator 59

HeartRhythm

APRIL 30, 2024

Non-sustained ventricular tachycardia (NSVT) is a predictor of sustained ventricular arrhythmias (VA) among implantable cardioverter defibrillator (ICD) recipients. We hypothesized that that a history of NSVT in primary prevention ICD recipients may parallel the risk profile observed in secondary prevention ICD recipients.

Tachycardia 40

Tachycardia Defibrillator Arrhythmia Outcomes 40

Circulation

JULY 10, 2024

The rapid technological advancements in cardiac implantable electronic devices such as pacemakers, implantable cardioverter defibrillators, and loop recorders, coupled with a rise in the number of patients with these devices, necessitate an updated clinical framework for periprocedural management.

Defibrillator 49

Defibrillator Pacemaker Nursing Technology 49

HeartRhythm

APRIL 30, 2024

Studies of sudden cardiac death (SCD) risk intend to specify substrate for fatal arrhythmia rescuable by defibrillator but presume cardiac cause. The Postmortem Systematic Investigation of SCD (POST SCD) study showed nearly half of presumed SCDs (pSCDs) are due to non-arrhythmic causes (e.g., overdose, stroke, tamponade).

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator Arrhythmia Stroke 40

Dr. Smith's ECG Blog

JULY 21, 2024

However, he suddenly developed a series of malignant ventricular arrhythmias. He required multiple defibrillations within a period of a few hours. Below are printouts of some of the arrhythmias recorded. This time, the arrhythmia did not spontaneously terminate — but rather degenerated to VFib, requiring defibrillation.

Arrhythmia 113

Arrhythmia Cardiogenic Shock Bradycardia Defibrillator 113

HeartRhythm

APRIL 30, 2024

Loss-of-function SCN5A channelopathies, such as Brugada syndrome (BrS), are cardiac disorders marked by diminished sodium current (INa), conduction slowing, and lethal arrhythmias.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

Frontiers in Cardiovascular Medicine

JUNE 3, 2024

During the intravenous lacosamide infusion, the patient developed sudden cardiac arrest caused by ventricular arrhythmias necessitating resuscitation. BackgroundLacosamide is frequently used as a mono- or adjunctive therapy for the treatment of adults with epilepsy. Of note, the patient had a family history of sudden cardiac death.

Sudden Cardiac Death 52

Sudden Cardiac Death Coronary Angiogram Cardiac Arrest Laboratory 52

HeartRhythm

JUNE 3, 2024

Most patients with VT and structural heart disease preparing for ablation either have or are about to receive an implantable cardioverter defibrillator (ICD) shortly after the procedure to prevent sudden cardiac death from recurrent ventricular arrhythmias (VA).

Sudden Cardiac Death 40

Sudden Cardiac Death Tachycardia Ablation Defibrillator 40

All About Cardiovascular System and Disorders

APRIL 17, 2024

Ventricular tachycardia is a potentially life threatening cardiac arrhythmia. Recurrent ventricular tachycardia in spite of radiofrequency catheter ablation needs an implantable cardioverter defibrillator. If the rate is very fast, hemodynamic deterioration can occur rapidly.

Tachycardia 52

Tachycardia Defibrillator Congenital Ischemia 52

Circulation

NOVEMBER 11, 2024

This can initiate ventricular arrhythmias like polymorphic ventricular tachycardia (PMVT). She was externally defibrillated with 200J and received magnesium and an IV amiodarone bolus. She was successfully defibrillated with 360J. Circulation, Volume 150, Issue Suppl_1 , Page A4143264-A4143264, November 12, 2024.

Tachycardia 40

Tachycardia Pacemaker Defibrillator Atrial Fibrillation 40